Literature DB >> 15567360

Oral fungal infections.

Brian C Muzyka1.   

Abstract

Candidiasis is the most common oral fungal infection diagnosed in humans. Candidiasis may result from immune system dysfunction or as a result of local or systemic medical treatment. Because oral candidiasis is generally a localized infection, topical treatment methods are the first line of therapy, especially for the pseudomembranous and erythematous variants. Patients with dental prostheses should also be advised to disinfect the prosthesis routinely during the candidal treatment period, because the prosthesis may serve as a source of reinfection. Additionally, patients should be advised that oral hygiene aids, such as toothbrushes and denture brushes, may also be contaminated and should be discarded or disinfected. A disinfecting solution of equal parts of hydrogen peroxide and water may be used. Likewise, 2% chlorhexidine gluconate solution may be used asa disinfecting solution for dental prostheses and oral hygiene aids. Occasionally the clinician encounters a more resistant form of oral candidiasis such as the hyperplastic variant or a variant that does not respond to topical therapy. Appropriate systemic therapy should be employed for the treatment of these infections. Additionally, a biopsy should be undertaken in individuals with the hyperplastic variant of Candida because there is some degree of risk for malignant transformation. Deep fungal infections should be managed in association with appropriate medical specialists to rule out other systemic involvement. The dental health care provider plays an important part in the diagnosis and management of fungal disease, and therefore clinicians should be aware of the presenting signs and symptoms or oral fungal disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15567360     DOI: 10.1016/j.cden.2004.07.007

Source DB:  PubMed          Journal:  Dent Clin North Am        ISSN: 0011-8532


  9 in total

1.  Reduced biocide susceptibility in Candida albicans biofilms.

Authors:  Jeniel E Nett; Kristie M Guite; Alex Ringeisen; Kathleen A Holoyda; David R Andes
Journal:  Antimicrob Agents Chemother       Date:  2008-06-23       Impact factor: 5.191

2.  Epithelial GM-CSF induction by Candida glabrata.

Authors:  L Li; A Dongari-Bagtzoglou
Journal:  J Dent Res       Date:  2009-08       Impact factor: 6.116

3.  Invitro Antifungal Evaluation of Denture Soft Liner Incorporated with Tea Tree Oil: A New Therapeutic Approach Towards Denture Stomatitis.

Authors:  Koteswara Rao Pachava; Lakshmi Kavitha Nadendla; Leela Subhashini Choudary Alluri; Huma Tahseen; Navya Poojitha Sajja
Journal:  J Clin Diagn Res       Date:  2015-06-01

4.  Comparison of salivary Candida profile in patients with fixed and removable orthodontic appliances therapy.

Authors:  Elham Khanpayeh; Abbas Ali Jafari; Zohre Tabatabaei
Journal:  Iran J Microbiol       Date:  2014-08

5.  An In Vitro Model for Oral Mixed Biofilms of Candida albicans and Streptococcus gordonii in Synthetic Saliva.

Authors:  Daniel Montelongo-Jauregui; Anand Srinivasan; Anand K Ramasubramanian; Jose L Lopez-Ribot
Journal:  Front Microbiol       Date:  2016-05-12       Impact factor: 5.640

6.  Spectrum of Lip Lesions in a Tertiary Care Hospital: An Epidemiological Study of 3009 Indian Patients.

Authors:  Shivani Bansal; Sana Shaikh; Rajiv S Desai; Islam Ahmad; Pavan Puri; Pooja Prasad; Pankaj Shirsat; Dipali Gundre
Journal:  Indian Dermatol Online J       Date:  2017 Mar-Apr

7.  Candida Cardiac Tamponade Secondary to Oesophageal-Pericardial Fistula: A Rare Presentation of Oesophageal Squamous Cell Carcinoma.

Authors:  Monther Ghunaim; Ali Someili; Mohammad Mawardi
Journal:  Eur J Case Rep Intern Med       Date:  2022-03-08

8.  Cancer risk in patients with candidiasis: a nationwide population-based cohort study.

Authors:  Li-Min Chung; Ji-An Liang; Cheng-Li Lin; Li-Min Sun; Chia-Hung Kao
Journal:  Oncotarget       Date:  2017-06-29

9.  Antifungal Activity of Commercial Essential Oils and Biocides against Candida Albicans.

Authors:  Elisa Serra; Lilia Araida Hidalgo-Bastida; Joanna Verran; David Williams; Sladjana Malic
Journal:  Pathogens       Date:  2018-01-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.